Filter
1816
Text search:
ART
therapy
Featured
184
603
Language
Document type
1176
232
192
85
37
35
33
6
5
4
4
3
1
1
Countries
119
75
64
63
53
50
48
48
44
40
34
34
31
30
27
27
26
22
22
22
22
20
20
17
16
16
16
16
16
14
13
11
10
10
9
7
7
7
6
5
5
5
5
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
923
155
77
54
44
36
13
1
Toolboxes
250
225
124
56
42
34
31
30
29
19
17
17
12
11
10
10
9
8
6
6
5
4
4
1
1
During ARV drug pressure the HIV-1 RT is able to develop resistance to these drugs by generating mutations
ATIC Newsletter, Vol 15, Issue 1,
February 2022.
These guidelines, produced in 2022 by the Uganda Ministry of Health, provide guidance on the diagnosis of HIV, the care of people living with HIV, and the use of antiretroviral drugs for treating and preventing HIV infection, including injectable cabotegravir and the dapivirine vaginal ring.
what lessons can we take from the last few decades of health behaviour change efforts as we enter the era of HIV prevention pills, rings and injections?
Questions and answers. A key priority is preventing the interruption of current HIV treatment and prevention medicines. This Q&A outlines advice when this is not possible. Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
These 2025 guidelines respond to the need for better approaches to identify advanced HIV disease, improve the poor outcomes of people living with HIV being discharged from hospital and provide updated guidance for treatment for Kaposi’s sarcoma through evidence-informed recommendations. The public
...
About six in ten adolescents 10-19 years of age living with HIV are on antiretroviral medications
Slightly more than half of children under 15 years of age living with HIV are on antiretroviral medications
JAMA. 2025;333(7):609–628. doi:10.1001/jama.2024.24543
Recent suspensions and reductions in official development assistance (ODA) have posed significant challenges to HIV programme continuity in several countries. These funding disruptions have impacted people living with HIV and other vulnerable populations
who rely on these essential services, like a
...
Dosing of LPV/r by formulation & dose modification (RTV super-boosting/double-dose LPV/r) for children receiving rifampicin-containing TB treatment. Chart
Annexure 6 National Guidelines South Africa 2023
The emergence of high-level dolutegravir resistance was extremely rare in people switched to first-line dolutegravir-based treatment in Zambia and Malawi, a large prospective study has found.
Modelling shows that it will be essential to complement lenacapavir with additional prevention options, testing and treatment. See “Meeting reports” at https://www.unaids.org/en/resources/publications/all for a description of models and tools to estimate potential impact and quantifications requ
...
Southern African Journal of HIV Medicine
A Guide for Community Case Workers in OVC Programs. This guide is meant to help you, a community case worker or
facility case manager working on an orphans and vulnerable children (OVC) program, to understand your role in supporting
multi-month dispensing (MMD) of anti-retroviral (ARV) medicines f
...
Este curso introduce la prevención combinada del VIH y la PrEP (profilaxis preexposición), brindando herramientas técnicas para su correcta implementación y seguimiento en la región.
This course introduces combined HIV prevention and PrEP (pre-exposure prophylaxis), providing technical tools for its proper implementation and monitoring in the region.
WHO has developed this series of modules to support the implementation of PrEP among a range of populations in different settings.
The tool contains modules for a range of stakeholders to support them in the consideration, planning, introduction and implementation of oral PrEP. The modules can b
...
Chapter 1 provides new data on the latest developments in the global treatment effort, highlighting positive trends as well as aspects that require improvement. Chapter 2 summarizes the impact of the scale-up in reducing AIDS-related mortality and new HIV infections. Chapter 3 examines the sequence
...
